D. Markovitz - Engineering a therapeutic Lectin: uncoupling mitogenicity from antiviral activity

Share:

Infectious Diseases

Science


David Markovitz, Department of Internal Medicine, University of Michigan, Michigan, MI, USA speaks on "Engineering a therapeutic Lectin: uncoupling mitogenicity from antiviral activity". This seminar has been recorded by ICGEB Trieste.